Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 116

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1
Chunk 116
---
 under Equity Incentive Plan 
     32,767  
     528,926 
  
    Deemed Capital Contribution for Related Party Compensation Expense (Note 10) 
        
     163,228 
  
    Loss on Debt Extinguishment 
     -  
     1,231,480 
  
    Change in Fair Value of Derivative Liabilities 
     (1,665,966) 
     37,278 
  
    Derivative Expense 
     -  
     399,725 
  
    Change in Fair Value of Promissory Note 
     -  
     (5,379,269)
  
    Write-offs of Capitalized Patents 
     108,424  
     - 
  
    Inventory Reserve 
     -  
     (160,338)
  
    Changes in Operating Assets and Liabilities: 

    Accounts Receivable 
     (255,416) 
     (185,367)
  
    Prepaid and Other Assets 
     (39,423) 
     (522,370)
  
    Inventory 
     23,405  
     212,747 
  
    Accounts Payable and Accrued Liabilities 
     501,412  
     (214,734)
  
    Accrued Interest, net 
     (23,604) 
     1,265,361 
  
    Reduction of Lease Liability 
     (13,650) 
     (50,273)
  
    Deferred Compensation 
     -  
     (100,000)
  
    Net Cash Used in Operating Activities 
     (5,648,088) 
     (4,542,910)

    CASH FLOWS FROM INVESTING ACTIVITIES 

    Capitalization of Patents 
     (51,967) 
     (39,982)
  
    Purchases of Fixed Assets 
     (103,773) 
     (57,623)
  
    Acquisition of Intangibles 
     (25,374) 
     (18,283)
  
    Purchase of Short-Term Investments 
     (1,708,000) 
     - 
  
    Net Cash Used in Investing Activities 
     (1,889,114) 
     (115,888)

    CASH FLOWS FROM FINANCING ACTIV